Neuren Pharmaceuticals (ASX:NEU) announces changes leadership team - Sequoia Direct Pty Ltd

27MayMay 27, 2020

Neuren Pharmaceuticals (ASX:NEU) announces changes leadership team

Neuren Pharmaceuticals (ASX:NEU) today announced the appointment of Jon Pilcher and Patrick Davies as Chief Executive Officer and non-executive Chair respectively.

These changes follow Richard Treagus’ decision to stand down after over 7 years as Executive Chairman to enable him to focus on his other business interests.

Jon started at Neuren as CFO in 2013 and is ideally suited to lead Neuren as it moves forward to realise the value of two drugs across multiple childhood disorders with urgent unmet need.

Patrick joined the Neuren board as a non-executive director in July 2018.

His experience includes 10 years as CEO of EBOS Group (formerly Symbion) during which the enterprise value grew from $450 million to more than $3.1 billion.

Shares in Neuren Pharmaceuticals (ASX:NEU) are trading 5.95 per cent higher at $1.78.

Copyright 2020 – Finance News Network

Source: Finance News Network

Related Posts

23MarMarch 23, 2020

Select Harvests (ASX:SHV) says almond harvest to continue

23 Mar 2020 - Paul Thompson, Managing Director of almond business Select Harvests (ASX:SHV), has confirmed all Select Harvests’ facilities and almond harvest will continue to operate.

07FebFebruary 7, 2020

News Corporation (ASX:NWS) report 6% decline in revenue

07 Feb 2020 - News Corporation (ASX:NWS) today reported financial results for the three months ending December 31, 2019 showing a 6 per cent decline in revenues at $2.48 billion compared to $2.63 billion in the previous year.

23DecDecember 23, 2019

Caltex Australia (ASX:CTX) is to change its name to Ampol

23 Dec 2019 - Caltex Australia (ASX:CTX) has received a termination notice from Chevron Corporation regarding its current licence agreement for use of the Caltex brand in Australia.

04OctOctober 4, 2023

Stocks of the Hour: Noxopharm, Redstone Resources, Lake Resources

04 Oct 2023 - A snapshot of the stocks on the move, featuring Noxopharm (ASX:NOX), Redstone Resources (ASX:RDS) and Lake Resources (ASX:LKE).

01JulJuly 1, 2020

Telix (ASX:TLX) granted FDA Break Through status for cancer treatment

01 Jul 2020 - Telix Pharmaceuticals (ASX:TLX) reports that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy (BT) designation for Telix’s renal cancer imaging product.

30JanJanuary 30, 2020

iSignthis (ASX:ISX) to face ASX in court next month

30 Jan 2020 - iSignthis (ASX:ISX) shares continue to be suspended after it started legal proceedings against the ASX on October 2nd.

30DecDecember 30, 2019

AVITA Medical (ASX:AV) secures FDA approval

30 Dec 2019 - AVITA Medical (ASX:AVH, NASDAQ:RECEL) has announced the resignation of joint company secretary Tamara Barr and secured US FDA approval to conduct a feasibility study evaluating the safety and effectiveness of the RECELL® Autologous Cell Harvesting Device for repigmentation of lesions.

12FebFebruary 12, 2024

Stocks of the Hour: BluGlass, Vection Technologies, Lake Resources

12 Feb 2024 - A snapshot of the stocks on the move, featuring BluGlass (ASX:BLG), Vection Technologies Ltd (ASX:VR1) and Lake Resources (ASX:LKE).

04SepSeptember 4, 2019

Pilbara Minerals announce equity raising for Chinese battery company

04 Sep 2019 - Pilbara Minerals (ASX:PLS) has announced an equity raising with a strategic placement of $55.0 million to the leading Chinese battery manufacturer for electric vehicles, Contemporary Amperex Technology.

19AprApril 19, 2021

Seven Group Holdings (ASX:SVW) to raise $500 million

19 Apr 2021 - Seven Group Holdings (ASX:SVW) has announced an equity raising to provide balance sheet flexibility.